Subject(s)
Adenocarcinoma/pathology , Adenocarcinoma/secondary , Erythema/pathology , Skin Neoplasms/pathology , Skin Neoplasms/secondary , Skin/pathology , Adenocarcinoma/complications , Biopsy , Breast , Breast Neoplasms , Carcinoma, Ductal, Breast , Erythema/diagnosis , Erythema/etiology , Female , Humans , Middle Aged , Skin Neoplasms/complicationsABSTRACT
Breast and nipple skin is commonly affected by various inflammatory and neoplastic processes. Despite this fact, many physicians are unaware of the spectrum of diseases that can involve this area. Because breast and nipple skin represents a cosmetically, sexually, and functionally important entity to most patients, awareness of these disease entities is invaluable. This article reviews the normal anatomy of the breast, cutaneous manifestations of neoplastic processes that can present in these areas, and common inflammatory diseases of the breast and nipple skin.
Subject(s)
Breast Diseases/pathology , Dermatitis/pathology , Mastitis/pathology , Anticoagulants/adverse effects , Breast Diseases/diagnosis , Breast Diseases/etiology , Breast Neoplasms/complications , Dermatitis/diagnosis , Dermatitis/etiology , Female , Hidradenitis Suppurativa/pathology , Humans , Necrosis , Nipples/pathology , Panniculitis, Lupus Erythematosus/pathology , Scleroderma, Localized/pathology , Warfarin/adverse effectsABSTRACT
UNLABELLED: Chemotherapeutic agents are a widely used treatment modality. Side effects range from common to unusual and may be confused with other cutaneous sequelae of oncologic treatment. The goal of this communication is to elaborate on previous descriptions of the cutaneous manifestations of chemotherapeutic treatment and to discuss more recent findings. LEARNING OBJECTIVE: At the conclusion of this learning activity, participants should be able to generate a differential diagnosis of possible etiologies for varying patterns of cutaneous involvement in patients receiving chemotherapy and identify the various cutaneous side effects of chemotherapeutic treatment. In addition, they should be able to distinguish life-threatening side effects that require immediate management from more benign manifestations of chemotherapeutic treatment.
